Skip to main content
VSEE
NASDAQ Industrial Applications And Services

VSee Health Registers 33.8 Million Shares for Resale, Signaling Substantial Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.44
Mkt Cap
$14.24M
52W Low
$0.363
52W High
$2.52
52W Position info
21% above low
Off High info
83% below high
Rel. Volume
Market data snapshot near publication time

VSEE sits 21% above its 52-week low of $0.363.

Summary

VSee Health filed a prospectus to register 33.8 million shares of common stock for resale by selling stockholders, representing over 100% of its currently outstanding shares and indicating substantial future dilution.


Key Events · Financing and Capital Events · VSEE

  • Massive Potential Dilution

    Up to 33,808,195 shares of common stock are registered for resale, which is more than the 33,193,140 shares currently outstanding, potentially doubling the share count.

  • Selling Stockholders Identified

    The primary selling stockholders are Armistice Capital Master Fund Ltd. and Manatt, Phelps & Phillips, LLP.

  • Origin of Shares

    These shares are issuable upon the exercise of warrants (Armistice) and conversion of Series B Preferred Stock (Manatt), which were issued in recent private placements.

  • Company Proceeds from Exercises

    VSee Health will not receive proceeds from the resale of these shares, but expects to receive approximately $12.0 million from the cash exercise of the underlying warrants.


Analysis · VSEE · Industrial Applications And Services

This 424B3 filing is a critical event for VSee Health, as it registers 33.8 million shares of common stock for resale by selling stockholders. This volume represents over 100% of the company's currently outstanding shares, indicating a highly dilutive offering that could exert significant downward pressure on the stock price. While the company will not receive proceeds from the resale of these shares, it anticipates approximately $12.0 million from the cash exercise of the underlying warrants and preferred stock. This capital is crucial for VSee Health, which recently faced a "going concern" warning and just regained Nasdaq compliance. However, the substantial increase in the tradable share float, coupled with the fact that many of the underlying instruments were issued at prices at or below the current market price, suggests a challenging capital-raising environment and a high cost to existing equity holders.

At the time of this filing, VSEE was trading at $0.44 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $14.2M. The 52-week trading range was $0.36 to $2.52. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VSEE - Latest Insights

VSEE
Jul 24, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0801
Real-time Price: $0.0744 info
Change: -$0.0057 (-7%) info
Market Cap: $4.143M info
VSEE
Jul 20, 2026, 8:30 AM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.0975
Real-time Price: $0.0744 info
Change: -$0.0231 (-24%) info
Market Cap: $4.143M info
VSEE
Jul 10, 2026, 4:35 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.110
Real-time Price: $0.0744 info
Change: -$0.0356 (-32%) info
Market Cap: $4.143M info
VSEE
Jul 07, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.1089
Real-time Price: $0.0744 info
Change: -$0.0345 (-32%) info
Market Cap: $4.143M info
VSEE
Jun 26, 2026, 4:35 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.1016
Real-time Price: $0.0744 info
Change: -$0.0272 (-27%) info
Market Cap: $4.143M info